D. Connelly

发表

Use of implantable cardioverter defibrillators in patients with left ventricular assist devices

M. Petrie, J. Payne, S. Haj‐Yahia, 2012, European journal of heart failure.

Who needs an implantable cardioverter‐defibrillator? Controversies and opportunities after DANISH

M. Petrie, R. Gardner, D. Connelly, 2018, European journal of heart failure.

Implantable cardioverter-defibrillators

D. Connelly, 2001, Heart.

Novel oral anticoagulants for the prevention of thromboembolism in patients with atrial fibrillation.

N. Lang, D. Connelly, 2013, The journal of the Royal College of Physicians of Edinburgh.

Implantable defibrillators for life threatening ventricular arrhythmias

D. Connelly, J. Causer, J. P. Causer, 1998, BMJ.

Interventricular lead separation is critical for NT-proBNP reduction after cardiac resynchronization therapy.

N. Lang, S. Pettit, R. Gardner, 2014, Biomarkers in medicine.

First prospective, multi-centre clinical experience with a novel left ventricular quadripolar lead.

G. Boriani, C. Rinaldi, R. Schilling, 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

ICDs in end-stage heart failure

F. Mair, C. May, U. Macleod, 2012, BMJ Supportive & Palliative Care.

European Counterpoint to Chapter 23

D. Connelly, 2006 .

The simultaneous use of a biventricular implantable cardioverter defibrillator (ICD) and transcutaneous electrical nerve stimulation (TENS) unit: implications for device interaction.

M. Chester, D. Connelly, J. Pyatt, 2003, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Clinical Experience of Subcutaneous and Transvenous Implantable Cardioverter Defibrillators in Children and Teenagers

A. McLean, S. Pettit, S. Pettit, 2013, Pacing and clinical electrophysiology : PACE.

Current controversies in using electrical devices

D. Connelly, 2009 .

A Small and Low-Cost Eye-Tracking System for Amyotrophic Lateral Sclerosis Patients

D. Connelly, M. Abdallah, R. Hassan, 2018 .

A pilot cluster randomised controlled trial of nurse-led heart failure clinics in primary care

F. Mair, S. Capewell, F. Lloyd-Williams, 2004 .

Trends in pacemaker mode prescription 1984-1994: a single centre study of 3710 patients.

S. Ray, R. Charles, D. Connelly, 1996, Heart.

Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems.

J. Ball, S. Ray, R. Charles, 1995, British heart journal.

Low Energy Catheter Ablation of a Posteroseptal Accessory Pathway Associated with a Diverticulum of the Coronary Sinus

E. Rowland, D. Cunningham, D. Connelly, 1991, Pacing and clinical electrophysiology : PACE.

Effects of intravenous adenosine in patients with preexcited junctional tachycardias: therapeutic efficacy and incidence of proarrhythmic events.

J. Camm, E. Rowland, D. Ward, 1994, The American journal of cardiology.

Single chamber atrial pacing: an underused and cost-effective pacing modality in sinus node disease

K. W. Clarke, R. Charles, D. Connelly, 1998, Heart.

Acute and early complications of permanent pacing: A prospective audit of 926 consecutive patients from a UK center

S. Ray, R. Charles, D. Connelly, 1996 .

Changing trends in pacemaker prescription in patients aged 80 and over: A single center audit of 962 patients

S. Ray, R. Charles, D. Connelly, 1996 .

The psychosocial impact of the implantable cardioverter defibrillator: a meta-analytic review.

D. Clark-Carter, D. Connelly, C. Hallas, 2003, British journal of health psychology.

Mobitz Type I Atrioventricular Block: An Indication for Permanent Pacing?

D. Steinhaus, D. Connelly, 1996, Pacing and clinical electrophysiology : PACE.

Isolated left ventricular non-compaction in a patient with pre-excited atrial fibrillation.

D. Connelly, S. Aziz, 2005, International journal of cardiology.

Cost savings with nonthoracotomy implantable cardioverter-defibrillators.

D. Steinhaus, D. Connelly, D. Cardinal, 1996, The American journal of cardiology.

A novel approach for a novel combination: a trans-septal biopsy of left atrial mass in recurrent phyllodes tumour.

C. Jackson, R. Gardner, D. Connelly, 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

A Prospective 1-Year Study of Changes in Neuropsychological Functioning After Implantable Cardioverter-Defibrillator Surgery

D. Connelly, C. Hallas, J. L. Burke, 2010, Circulation. Arrhythmia and electrophysiology.

Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial

J. McMurray, N. Hawkins, M. Petrie, 2010, Heart.

Clinical indications for genetic testing in familial sudden cardiac death syndromes: an HRUK position statement

P. Lambiase, E. Behr, W. Mckenna, 2007, Heart.

Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort

F. Mair, B. Jani, P. Hanlon, 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Does treatment with ACE inhibitors or angiotensin II receptor antagonists prevent atrial fibrillation after dual chamber pacemaker implantation?

S. Williams, K. Albouaini, D. Todd, 2005, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

An entirely subcutaneous implantable cardioverter-defibrillator.

Alexander H Maass, Johannes Sperzel, Riccardo Cappato, 2010, The New England journal of medicine.

Why are patients in clinical trials of heart failure not like those we see in everyday practice?

F. Mair, S. Capewell, B. Hanratty, 2003, Journal of clinical epidemiology.

Long-term survival after permanent pacemaker implantation: analysis of predictors for increased mortality.

R. Charles, D. Connelly, M. Jackson, 2002, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Sexual dysfunction in cardiovascular disease

F. Mair, M. Aitchison, D. Morrison, 2011, BMJ : British Medical Journal.

Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy.

J. Bourke, J. Morgan, A. Grace, 2008, European heart journal.

Wolff-Parkinson-White Syndrome (WPW)

T. Lobban, D. Connelly, NigelO ' Farrell, 2010 .

When to consider an implantable cardioverter defibrillator following myocardial infarction?

Benjamin R. Szwejkowski, R. Gardner, D. Connelly, 2015, Heart.

Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable haemodynamic monitor: results of a 1 year multicentre feasibility study.

S Adler, L. Rydén, D. Steinhaus, 2001, European heart journal.

Atrial Pacing Leads Following Open Heart Surgery: Active or Passive Fixation?

D. Steinhaus, D. Connelly, D. Cardinal, 1997, Pacing and clinical electrophysiology : PACE.